Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor.

Documenti analoghi

• Prevention of EAE in non-human primates by a type IV phosphodiesterase inhibitor that suppresses tumor necrosis factor
  di: Genain, C.P., et al.
  Pubblicazione: (1994)
• Regulation of cAMP by Phosphodiesterases in Erythrocytes
  di: Adderley, Shaquria P., et al.
  Pubblicazione: (2010)
• Conditions that alter intracellular cAMP levels affect expression of the cAMP phosphodiesterase gene in Dictyostelium.
  di: Riley, B B, et al.
  Pubblicazione: (1990)
• Phosphodiesterases and cAMP Pathway in Pituitary Diseases
  di: Bizzi, Mariana Ferreira, et al.
  Pubblicazione: (2019)
• Investigation of the Alkenyldiarylmethane Non-nucleoside Reverse Transcriptase Inhibitors as Potential cAMP Phosphodiesterase-4B2 Inhibitors
  di: Cullen, Matthew D., et al.
  Pubblicazione: (2007)